Wilmington Savings Fund Society FSB decreased its position in MetLife, Inc. (NYSE:MET – Free Report) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,264 shares of the financial services provider’s stock after selling 234 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in MetLife were worth $677,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the company. PFG Investments LLC increased its stake in MetLife by 8.9% during the 3rd quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock worth $525,000 after buying an additional 520 shares during the period. CX Institutional boosted its holdings in MetLife by 15.9% in the fourth quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock valued at $5,568,000 after purchasing an additional 9,337 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in MetLife during the 3rd quarter valued at approximately $2,960,000. Meeder Asset Management Inc. increased its holdings in MetLife by 48,101.4% during the 3rd quarter. Meeder Asset Management Inc. now owns 106,043 shares of the financial services provider’s stock worth $8,746,000 after purchasing an additional 105,823 shares during the last quarter. Finally, Segall Bryant & Hamill LLC acquired a new position in shares of MetLife in the 3rd quarter valued at approximately $1,074,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
A number of brokerages recently issued reports on MET. BMO Capital Markets assumed coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target for the company. JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company lowered their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a report on Tuesday, January 14th. Barclays decreased their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday. Finally, TD Cowen raised their price objective on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $91.08.
MetLife Price Performance
Shares of NYSE:MET opened at $83.12 on Tuesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The firm’s 50 day moving average is $83.72 and its two-hundred day moving average is $80.88. The firm has a market capitalization of $57.55 billion, a P/E ratio of 13.92, a PEG ratio of 0.64 and a beta of 1.07. MetLife, Inc. has a 52 week low of $67.04 and a 52 week high of $89.05.
MetLife (NYSE:MET – Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Analysts anticipate that MetLife, Inc. will post 9.63 earnings per share for the current year.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.62%. MetLife’s payout ratio is 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Conference Calls and Individual Investors
- Merck: 4 No-Brainer Reasons to Buy This Dip
- What Investors Need to Know About Upcoming IPOs
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Invest in Biotech Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.